Latest news on Laboratorytalk categorised by supplier
Chimera Biotec
Address:
Emil-Figge-Str 76A Dortmund
D-44227
Germany
Telephone: (Germany) +49 231 9742 840
http://www.chimera-biotec.com
Our RSS feed for news from Chimera Biotec
Request to receive our free email newsletter each week
Listing of all 9 news releases from Chimera Biotec:
Chimera invites scientists to 3rd Immunolympics
Technical background article For the third time Chimera Biotec supports the scientific community with a contest on ultra-sensitive immunoassays: the third Immunolympics are open
News from Chimera Biotec ( 2 June 2008)
AbD Serotec and Chimera Biotec extend agreement
Companies agree to co-market the rapid generation of monoclonal antibodies by AbD Serotec and Chimera Biotec's complementary Imperacer assay technology for ultra-sensitive antigen detection
News from Chimera Biotec ( 4 May 2007)
Novel biomarker detection for Alzheimer's disease
Technical background article Chimera Biotec joins the EU funded Edar project to adapt the Imperacer platform technology for the detection of novel biomarkers for the diagnosis of Alzheimer's disease
News from Chimera Biotec (12 March 2007)
Putting neurological disorders to the test
Technical background article Contest seeks to find potential solutions to today's scientific challenges using the highly sensitive chimera Imperacer technology
News from Chimera Biotec (18 December 2006)
Chimera addresses highly sensitive immunoassay
Technical background article Chimera Biotec's Ron Wacker addresses ultra-high sensitive immunoassay technology at the Association for Molecular Pathology annual meeting
News from Chimera Biotec (29 November 2006)
Athletic doping gets 1000 times harder to hide
Steroids and other forms of illegal substance abuse are 1000 times easier to detect in athletes thanks to a new highly sensitive technology created by Chimera Biotec and German Sports University.
News from Chimera Biotec (18 September 2006)
Ultra-high sensitive immunoassay technology to USA
AvTech Laboratories and Chimera Biotec sign agreement that combines Chimera's ultra-high sensitive immunoassay technology, Imperacer, with AvTech's expertise in state-of-the-art analytical service
News from Chimera Biotec (18 September 2006)
Co-marketing agreement for monoclonal antibodies
Antibodies by Design, a division of MorphoSys, Munich, and Chimera Biotec have announced the start of a co-marketing agreement between the two companies
News from Chimera Biotec (27 February 2006)
Improve the sensitivity of Elisas 1000 times
Scientists benefit from an ultra-sensitive technology improving the existing assays by simply exchanging the fluorophor or enzyme labelled antibody by a DNA-antibody conjugate
News from Chimera Biotec (21 March 2005)
